BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2538716)

  • 1. Mechanism of activation of the human trk oncogene.
    Coulier F; Martin-Zanca D; Ernst M; Barbacid M
    Mol Cell Biol; 1989 Jan; 9(1):15-23. PubMed ID: 2538716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and biochemical characterization of the human trk proto-oncogene.
    Martin-Zanca D; Oskam R; Mitra G; Copeland T; Barbacid M
    Mol Cell Biol; 1989 Jan; 9(1):24-33. PubMed ID: 2927393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain.
    Coulier F; Kumar R; Ernst M; Klein R; Martin-Zanca D; Barbacid M
    Mol Cell Biol; 1990 Aug; 10(8):4202-10. PubMed ID: 1695324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The trk family of oncogenes and neurotrophin receptors.
    Lamballe F; Klein R; Barbacid M
    Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and biochemical characterization of p70TRK, product of the human TRK oncogene.
    Mitra G; Martin-Zanca D; Barbacid M
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6707-11. PubMed ID: 3477801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent generation of oncogenes by in vitro recombination of TRK protooncogene sequences.
    Oskam R; Coulier F; Ernst M; Martin-Zanca D; Barbacid M
    Proc Natl Acad Sci U S A; 1988 May; 85(9):2964-8. PubMed ID: 3362859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
    Mitra G
    Oncogene; 1991 Dec; 6(12):2237-41. PubMed ID: 1837350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific expression of the human tropomyosin gene involved in the generation of the trk oncogene.
    Reinach FC; MacLeod AR
    Nature; 1986 Aug 14-20; 322(6080):648-50. PubMed ID: 3018581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences.
    Martin-Zanca D; Hughes SH; Barbacid M
    Nature; 1986 Feb 27-Mar 5; 319(6056):743-8. PubMed ID: 2869410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the trk oncogene by alternatively spliced muscle and non-muscle tropomyosin sequences.
    Barnes D; Clayton L; Chumbley G; MacLeod AR
    Oncogene; 1989 Feb; 4(2):259-62. PubMed ID: 2927948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic rearrangement of the tropomyosin-receptor-kinase (trk) oncogene is rare in gastrointestinal cancer.
    Fey MF; Thein SL
    Br J Cancer; 1988 Apr; 57(4):403-4. PubMed ID: 3390374
    [No Abstract]   [Full Text] [Related]  

  • 13. The human tropomyosin gene involved in the generation of the TRK oncogene maps to chromosome 1q31.
    Radice P; Sozzi G; Miozzo M; De Benedetti V; Cariani T; Bongarzone I; Spurr NK; Pierotti MA; Della Porta G
    Oncogene; 1991 Nov; 6(11):2145-8. PubMed ID: 1834975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a.
    Ziemiecki A; Müller RG; Fu XC; Hynes NE; Kozma S
    EMBO J; 1990 Jan; 9(1):191-6. PubMed ID: 2403926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trk oncogene abrogates growth factor requirements and transforms hematopoietic cells.
    Katzav S; Martin-Zanca D; Barbacid M; Hedge AM; Isfort R; Ihle JN
    Oncogene; 1989 Sep; 4(9):1129-35. PubMed ID: 2674855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
    Takahashi M; Buma Y; Iwamoto T; Inaguma Y; Ikeda H; Hiai H
    Oncogene; 1988 Nov; 3(5):571-8. PubMed ID: 3078962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
    Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
    Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
    Eager KB
    Oncogene; 1991 May; 6(5):819-24. PubMed ID: 2052359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences.
    Kozma SC; Redmond SM; Fu XC; Saurer SM; Groner B; Hynes NE
    EMBO J; 1988 Jan; 7(1):147-54. PubMed ID: 2966065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
    Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
    Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.